Literature DB >> 15628993

Serum activity of Angiotensin converting enzyme and blood pressure response to acute dynamic exercise.

Emina Nakas-Ićindić1, Adnan Hadzimuratović, Jasminko Huskić, Almira Hadzović, Asija Zaciragić, Nesina Avdagić.   

Abstract

Angiotensin converting enzyme (ACE) plays an important role in blood pressure regulation not only in the state of rest, but also during physical exercise. The aim of this study was to estimate the serum ACE activity in response to acute dynamic exercise. The study involved a group of young, healthy, male volunteers (average 22 years of age). Exercise testing was carried out on ergometer bicycle according to the protocol of individually adjusted continuous, constant workload (3 W/kg). The activity of ACE in serum was measured in venous blood, in the period of rest, in 4th, 8th and 12th minute of exercise and 1st, 3rd and 6th minute of recovery by spectrophotometric method. Marked inter-individual differences in basal serum ACE activity were determined (range 8, 31-63, 72 U/L). Serum ACE activity did not significantly vary during exercise and in the period of recovery. Systolic blood pressure changed during exercise compared to values during rest period in accordance with the applied type of dynamical exercise. Diastolic blood pressure did not vary considerably during exercise. Statistically significant correlation between mean arterial blood pressure and ACE activity in the serum was not found. The lack of increase of ACE activity in the serum, in spite of changes in blood pressure values, most likely shows the presence of alternative ACE independent pathway involved in the production of vasoactive substances that have important role in the regulation of cardiovascular system response to acute dynamic exercise.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15628993      PMCID: PMC7245501          DOI: 10.17305/bjbms.2004.3357

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  11 in total

1.  Hormonal and renal responses to converting enzyme inhibition during maximal exercise.

Authors:  C E Wade; S R Ramee; M M Hunt; C J White
Journal:  J Appl Physiol (1985)       Date:  1987-11

Review 2.  Physiological and pharmacological aspects of angiotensin converting enzyme.

Authors:  F Fyhrquist; C Grönhagen-Riska; T Forslund; L Hortling
Journal:  Scand J Urol Nephrol Suppl       Date:  1984

3.  Simple radioassay for measuring serum activity of angiotensin-converting enzyme in sarcoidosis.

Authors:  P K Rohatgi; J W Ryan
Journal:  Chest       Date:  1980-07       Impact factor: 9.410

4.  Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study.

Authors:  F Cambien; F Alhenc-Gelas; B Herbeth; J L Andre; R Rakotovao; M F Gonzales; J Allegrini; C Bloch
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

Review 5.  Control of skeletal muscle perfusion at the onset of dynamic exercise.

Authors:  M D Delp
Journal:  Med Sci Sports Exerc       Date:  1999-07       Impact factor: 5.411

6.  Plasma renin system during exercise in normal men.

Authors:  J Staessen; R Fagard; P Hespel; P Lijnen; L Vanhees; A Amery
Journal:  J Appl Physiol (1985)       Date:  1987-07

7.  Angiotensin II formation by an alternative pathway during exercise in humans.

Authors:  S Miura; M Ideishi; T Sakai; M Motoyama; A Kinoshita; M Sasaguri; H Tanaka; M Shindo; K Arakawa
Journal:  J Hypertens       Date:  1994-10       Impact factor: 4.844

8.  Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.

Authors:  M L Lachurié; M Azizi; T T Guyene; F Alhenc-Gelas; J Ménard
Journal:  Circulation       Date:  1995-06-15       Impact factor: 29.690

9.  Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans.

Authors:  J C Aldigier; H Huang; F Dalmay; M Lartigue; T Baussant; A P Chassain; C Leroux-Robert; F X Galen
Journal:  J Cardiovasc Pharmacol       Date:  1993-02       Impact factor: 3.105

10.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Authors:  B Rigat; C Hubert; F Alhenc-Gelas; F Cambien; P Corvol; F Soubrier
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.